Categories: Economy

India Ratings decrease GDP growth at 8.6% for FY22

India Ratings has revised downwards its GDP growth forecast for 2021-22 to 8.6 per cent from the consensus 9.2 per cent projected earlier. According to an India rating analysis, National Statistical Organisation (NSO) is likely to peg the FY22 real gross domestic product growth at Rs 147.2 lakh crore. This translates into a GDP growth rate of 8.6 per cent, down from the 9.2 per cent forecast in the first advance estimate released on January 7, 2022.

Buy Prime Test Series for all Banking, SSC, Insurance & other exams

What is the major reason for downward revision?

The major reason for the likely downward revision is the upward revision of FY21 GDP to Rs 135.6 lakh crore in the first revised estimate of national income for FY21, which was released on January 31, 2022.

Find More News on Economy Here

Sumit Arora

As a team lead and current affairs writer at Adda247, I am responsible for researching and producing engaging, informative content designed to assist candidates in preparing for national and state-level competitive government exams. I specialize in crafting insightful articles that keep aspirants updated on the latest trends and developments in current affairs. With a strong emphasis on educational excellence, my goal is to equip readers with the knowledge and confidence needed to excel in their exams. Through well-researched and thoughtfully written content, I strive to guide and support candidates on their journey to success.

Recent Posts

Women’s U19 T20 World Cup 2027 to Begin on January 21 in Bangladesh and Nepal

The ICC U19 Women’s T20 World Cup 2027 is set to commence on January 21,…

8 hours ago

World Iodine Deficiency Day 2026: Causes, Symptoms, Prevention and India’s NIDDCP

Iodine Deficiency Day or World Iodine Deficiency Disorders Prevention Day is celebrated on October 21…

9 hours ago

Nigeria Reports Imported Case of Ebola Bundibugyo Virus Disease

There is an imported case of the Bundibugyo strain of the Ebola virus in the…

9 hours ago

DCGI Approves Zytorvi (Toripalimab) for Advanced Esophageal Cancer

On October 21, 2026, the Drugs Controller General of India (DCGI) approved Zytorvi (toripalimab) in…

11 hours ago

Ipsos Quality of Care Perception Index 2026: Malaysia Ranks First, India Third

India was ranked third in the Ipsos Quality of Care Perception Index 2026 after Malaysia…

11 hours ago

Jamnagar Refinery: Why India’s Oil Hub Matters to the World

Jamnagar is a coastal city in the state of the Gujarat and it is emerging…

11 hours ago